Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Current Deferred Tax Assets (2016 - 2018)

Historic Current Deferred Tax Assets for Prestige Consumer Healthcare (PBH) over the last 7 years, with Q1 2018 value amounting to $26000.0.

  • Prestige Consumer Healthcare's Current Deferred Tax Assets changed N/A to $26000.0 in Q1 2018 from the same period last year, while for Mar 2018 it was $26000.0, marking a year-over-year change of. This contributed to the annual value of $26000.0 for FY2018, which is N/A changed from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Current Deferred Tax Assets of $26000.0 as of Q1 2018.
  • Prestige Consumer Healthcare's Current Deferred Tax Assets' 5-year high stood at $12.6 million during Q4 2016, with a 5-year trough of $26000.0 in Q1 2018.
  • Moreover, its 4-year median value for Current Deferred Tax Assets was $8.3 million (2014), whereas its average is $8.2 million.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Current Deferred Tax Assets plummeted by 979.17% in 2015 and then surged by 4991.67% in 2016.
  • Quarter analysis of 4 years shows Prestige Consumer Healthcare's Current Deferred Tax Assets stood at $8.3 million in 2014, then increased by 0.72% to $8.4 million in 2015, then soared by 49.92% to $12.6 million in 2016, then tumbled by 99.79% to $26000.0 in 2018.
  • Its last three reported values are $26000.0 in Q1 2018, $12.6 million for Q4 2016, and $10.6 million during Q3 2016.